Serum Institute Applies for Market Authorisation of Covishield, SEC to Review Today

The subject expert committee of the Drugs Controller General of India will also consider today Bharat Biotech's application to conduct phase 2/3 clinical trials of vaccine on pregnant women.

from Top India News- News18.com https://ift.tt/3I0WmAn